Varex Imaging Corporation (VREX)
USD 10.32
(-9.76%)
USD 10.32
(-9.76%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 224.8 Million USD | 5.44% |
| 2023 | 213.2 Million USD | 9.17% |
| 2022 | 195.3 Million USD | -1.06% |
| 2021 | 197.4 Million USD | -10.72% |
| 2020 | 221.1 Million USD | 7.23% |
| 2019 | 206.2 Million USD | -1.53% |
| 2018 | 209.4 Million USD | 23.32% |
| 2017 | 169.8 Million USD | 21.9% |
| 2016 | 139.3 Million USD | 13.16% |
| 2015 | 123.1 Million USD | 19.98% |
| 2014 | 102.6 Million USD | 3.32% |
| 2013 | 99.3 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 57.6 Million USD | -0.86% |
| 2024 Q1 | 52.9 Million USD | -1.49% |
| 2024 Q2 | 58.1 Million USD | 9.83% |
| 2023 Q2 | 57.1 Million USD | 13.52% |
| 2023 Q1 | 50.3 Million USD | 0.8% |
| 2023 Q4 | 53.7 Million USD | 3.07% |
| 2023 FY | 213.2 Million USD | 9.17% |
| 2023 Q3 | 52.1 Million USD | -8.76% |
| 2022 Q1 | 50.8 Million USD | 3.46% |
| 2022 FY | 195.3 Million USD | -1.06% |
| 2022 Q4 | 49.9 Million USD | -0.99% |
| 2022 Q3 | 50.4 Million USD | 14.03% |
| 2022 Q2 | 44.2 Million USD | -12.99% |
| 2021 FY | 197.4 Million USD | -10.72% |
| 2021 Q4 | 49.1 Million USD | 1.45% |
| 2021 Q2 | 48.8 Million USD | -4.5% |
| 2021 Q3 | 48.4 Million USD | -0.82% |
| 2021 Q1 | 51.1 Million USD | -11.9% |
| 2020 Q1 | 56.5 Million USD | 1.99% |
| 2020 Q3 | 50.4 Million USD | -10.32% |
| 2020 Q4 | 58 Million USD | 15.08% |
| 2020 FY | 221.1 Million USD | 7.23% |
| 2020 Q2 | 56.2 Million USD | -0.53% |
| 2019 Q1 | 49.6 Million USD | -6.24% |
| 2019 FY | 206.2 Million USD | -1.53% |
| 2019 Q4 | 55.4 Million USD | -1.25% |
| 2019 Q3 | 56.1 Million USD | 12.42% |
| 2019 Q2 | 49.9 Million USD | 0.6% |
| 2018 FY | 209.4 Million USD | 23.32% |
| 2018 Q4 | 52.9 Million USD | -5.03% |
| 2018 Q1 | 47.9 Million USD | -6.26% |
| 2018 Q2 | 52.9 Million USD | 10.44% |
| 2018 Q3 | 55.7 Million USD | 5.29% |
| 2017 Q3 | 44 Million USD | 29.03% |
| 2017 FY | 169.8 Million USD | 21.9% |
| 2017 Q1 | 40.2 Million USD | 11.05% |
| 2017 Q2 | 34.1 Million USD | -15.17% |
| 2017 Q4 | 51.1 Million USD | 16.14% |
| 2016 Q1 | 34.5 Million USD | 0.58% |
| 2016 Q2 | 33.9 Million USD | -1.74% |
| 2016 Q4 | 36.2 Million USD | 4.62% |
| 2016 Q3 | 34.6 Million USD | 2.06% |
| 2016 FY | 139.3 Million USD | 13.16% |
| 2015 FY | 123.1 Million USD | 19.98% |
| 2015 Q4 | 34.3 Million USD | 0.0% |
| 2014 FY | 102.6 Million USD | 3.32% |
| 2013 FY | 99.3 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -1902.851% |
| Cerus Corporation | 143.15 Million USD | -57.033% |
| OrthoPediatrics Corp. | 137.01 Million USD | -64.065% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -1878.722% |
| Talis Biomedical Corporation | 67.18 Million USD | -234.594% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -801.146% |
| Inogen, Inc. | 236.08 Million USD | 4.78% |
| Spectral AI, Inc. | 20.86 Million USD | -977.454% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -301.45% |
| CVRx, Inc. | 76.14 Million USD | -195.238% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -6271.889% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -1699.984% |
| Orthofix Medical Inc. | 667.42 Million USD | 66.318% |
| Venus Concept Inc. | 80.47 Million USD | -179.338% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -297.328% |
| Bioventus Inc. | 409.91 Million USD | 45.16% |
| BrainsWay Ltd. | 28.01 Million USD | -702.341% |
| Envoy Medical, Inc. | 17.89 Million USD | -1156.006% |
| electroCore, Inc. | 32.03 Million USD | -601.82% |
| IceCure Medical Ltd | 16.87 Million USD | -1232.069% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -429.789% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -1174.88% |
| MaxCyte, Inc. | 84.84 Million USD | -164.954% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -1711.184% |
| Nexalin Technology, Inc. | 5.78 Million USD | -3788.361% |
| PAVmed Inc | 64.82 Million USD | -246.769% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -340.111% |
| RxSight, Inc. | 103.85 Million USD | -116.466% |
| Sight Sciences, Inc. | 126.44 Million USD | -77.779% |
| SI-BONE, Inc. | 156.35 Million USD | -43.779% |
| TELA Bio, Inc. | 84.18 Million USD | -167.025% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -220.886% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | -10.54% |
| LivaNova PLC | 843.54 Million USD | 73.351% |
| 908 Devices Inc. | 68.08 Million USD | -230.2% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 53.515% |
| Nemaura Medical Inc. | 7.13 Million USD | -3048.987% |
| NeuroPace, Inc. | 75.29 Million USD | -198.555% |
| LENSAR, Inc. | 33.33 Million USD | -574.346% |
| Apyx Medical Corporation | 51.01 Million USD | -340.629% |
| Cutera, Inc. | 197.72 Million USD | -13.694% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -807.147% |
| BioSig Technologies, Inc. | 28.53 Million USD | -687.943% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -17.404% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -523.405% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 73.123% |
| Axonics, Inc. | 270.2 Million USD | 16.803% |
| Outset Medical, Inc. | 198.77 Million USD | -13.096% |
| IRIDEX Corporation | 31.81 Million USD | -606.607% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -24.737% |
| IRadimed Corporation | 30.12 Million USD | -646.278% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -2534.787% |
| INVO Bioscience, Inc. | 7.85 Million USD | -2762.493% |
| Telesis Bio, Inc. | 63.48 Million USD | -254.077% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -128.332% |
| Quipt Home Medical Corp. | 148.66 Million USD | -51.21% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1817.598% |
| Pulmonx Corporation | 112.68 Million USD | -99.491% |
| Dynatronics Corporation | 9.9 Million USD | -2168.868% |
| Modular Medical, Inc. | 17.52 Million USD | -1182.446% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -1013.588% |
| Semler Scientific, Inc. | 38.94 Million USD | -477.239% |
| InMode Ltd. | 215.68 Million USD | -4.228% |
| Bruker Corporation | 1.07 Billion USD | 79.116% |
| Cytosorbents Corporation | 48.33 Million USD | -365.07% |
| DexCom, Inc. | 1.69 Billion USD | 86.708% |
| Align Technology, Inc. | 2.07 Billion USD | 89.176% |
| Viveve Medical, Inc. | 22.17 Million USD | -913.846% |
| ZimVie Inc. | 275.12 Million USD | 18.292% |
| Movano Inc. | 29.69 Million USD | -657.157% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -63.764% |
| Nexalin Technology, Inc. | 5.78 Million USD | -3788.361% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -6271.889% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 62.591% |
| Profound Medical Corp. | 33.6 Million USD | -568.985% |
| Insulet Corporation | 939.9 Million USD | 76.083% |
| enVVeno Medical Corporation | 25.23 Million USD | -790.72% |
| Surmodics, Inc. | 98.69 Million USD | -127.768% |
| iCAD, Inc. | 22.22 Million USD | -911.474% |
| Nuwellis, Inc. | 22.61 Million USD | -894.118% |
| Biotricity, Inc. | 17.18 Million USD | -1208.152% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 49.584% |
| Aethlon Medical, Inc. | 12.27 Million USD | -1730.99% |
| InspireMD, Inc. | 22.95 Million USD | -879.521% |
| PAVmed Inc. | 64.82 Million USD | -246.769% |
| BIOLASE, Inc. | 34.66 Million USD | -548.568% |
| Beyond Air, Inc. | 61.7 Million USD | -264.344% |
| FONAR Corporation | 28.6 Million USD | -685.885% |
| AxoGen, Inc. | 149.33 Million USD | -50.533% |
| Vivani Medical, Inc. | 26.96 Million USD | -733.673% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -26.94% |
| Inari Medical, Inc. | 448.59 Million USD | 49.888% |
| UFP Technologies, Inc. | 58.08 Million USD | -286.992% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -4462.06% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -3457.925% |
| Tenon Medical, Inc. | 16.96 Million USD | -1224.847% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -2940.714% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -409.718% |
| AdaptHealth Corp. | 1.07 Billion USD | 79.146% |
| Sintx Technologies, Inc. | 15.2 Million USD | -1378.85% |
| NanoVibronix, Inc. | 4.97 Million USD | -4420.41% |
| Quanterix Corporation | 118.1 Million USD | -90.347% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1817.598% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -1456.571% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 42.75% |
| TransMedics Group, Inc. | 182.82 Million USD | -22.962% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -700.998% |
| NeuroMetrix, Inc. | 11.09 Million USD | -1925.42% |
| Hyperfine, Inc. | 52.87 Million USD | -325.178% |
| Establishment Labs Holdings Inc. | 172 Million USD | -30.695% |
| Biomerica, Inc. | 6.97 Million USD | -3121.553% |
| Bone Biologics Corporation | 9.42 Million USD | -2284.31% |
| AVITA Medical, Inc. | 80.77 Million USD | -178.289% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -2080.15% |
| Silk Road Medical, Inc | 186.35 Million USD | -20.629% |